Article Details

Gilead Stock – Gilead Stock – WHO: Nations mulling Gilead's COVID drug should consider trial flop ...

Retrieved on: 2021-04-05 02:03:45

Tags for this article:

Click the tags to see associated articles and topics

Gilead Stock – Gilead Stock – WHO: Nations mulling Gilead's COVID drug should consider trial flop .... View article details on hiswai:

Excerpt

For the remdesivir arm of the WHO's Solidarity trial, 2,743 patients were given the treatment, compared to 2,708 in the control group. Gilead, which has ...

Article found on: fintechzoom.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up